Evaluation of Buspirone on Streptozotocin Induced Type 1 Diabetes and Its Associated Complications

Table 3

Effect of buspirone on serum cardiac markers and hypertrophic parameter.

Parameters	CON	COB	DIC	DIB
Lactate dehydrogenase (U/L)	724.57±61.32	750.82±55.99	1044.17±61.46^∗	822.35±53.51^#
C-reactive protein (mg/L)	0.99±0.16	1.08±0.17	2.78±0.27^∗	1.79±0.21^#
Creatinine kinase-MB (U/L)	324.32±16.17	358.12±13.83	459.58±12.58^∗	403.32±18.77^#
Cardiac hypertrophy index (mg/mm)	20.08±0.17	20.16±0.16	20.88±0.13^∗	20.50±0.08^#

∗Significantly different from normal control (𝑃<0.05).
^#Significantly different from diabetic control (𝑃<0.05).
Values are expressed as mean ± SEM of 6 experiments.
CON: normal control, COB: control treated with buspirone, DIC: diabetic control, and DIB: diabetic treated with buspirone.